Salarius Pharmaceuticals Clarifies Nasdaq Listing Status
ByAinvest
Monday, Nov 17, 2025 8:39 pm ET1min read
SLRX--
Salarius Pharmaceuticals reports that certain financial market data platforms have inaccurately stated that the company has been delisted from Nasdaq. The company's common stock is still listed and traded on the Nasdaq Capital Market under the ticker symbol "SLRX." Salarius had previously regained compliance with Nasdaq's minimum bid price and equity standards, and had completed a strategic merger transaction. The company has contacted the platforms to correct the inaccurate information.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet